Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
74.7M
-
Shares change
-
+5.09M
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$112M
-
Put/Call ratio
-
0.91
-
Number of buys
-
104
-
Number of sells
-
-98
-
Price
-
$26.40
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2024
259 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.7M shares
of 170M outstanding shares and own 43.99% of the company stock.
Largest 10 shareholders include FMR LLC (10.5M shares), VANGUARD GROUP INC (6.51M shares), BlackRock Inc. (4.92M shares), ARMISTICE CAPITAL, LLC (3.4M shares), Deep Track Capital, LP (2.88M shares), STATE STREET CORP (2.72M shares), VIKING GLOBAL INVESTORS LP (2.32M shares), PERCEPTIVE ADVISORS LLC (1.92M shares), Alpine Global Management, LLC (1.91M shares), and Woodline Partners LP (1.82M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.